JUMP REPORT
CHEWY, INC (CHWY)
EARNINGS RELEASE - SEPTEMBER 10 (AMC)
EARNINGS EXPECTATIONS:
THIS QTR: EPS: -.16/share REV: 1,690/M
___________________________________________________________
NEXT QTR: EPS: -.12/share REV: 1,700/M
____________________________________________________________
FULL YR: EPS: -.46/share REV: 6,850/M
____________________________________________________________
LAST QTR: EPS: -.16/share ACTUAL: -.12/share (BEAT)
____________________________________________________________
BEAT/MISS RECORD: 0% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -5.78, 9.35, 7.91
EXPECTED JUMP MOVE THIS QUARTER: 8-10+%
——–
*** With market volatility at extremes there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before trading.
Links To Latest News and Headlines
Veho, announced today the appointment of Scott Anderson, Chief Operations Officer of Chewy, to its Board.
Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription product intended to support normal stool consistency and GI fluid balance in dogs. The Neonorm franchise currently includes Neonorm Foal and Neonorm Calf, plant-based products developed to support proper hydration and bowel health in pre-weaned foals and calves.
Chewy stock has seen a steep pullback over the past five years, yet the current market multiples still point to an expensive profile rather than a clear bargain. The share price has fallen about 72% over five years, which means long term holders have seen a substantial loss in value. Chewy’s valuation hinges on whether the business can convert its customer base into consistent, higher margin cash flows, while any stumble in execution or profitability may keep pressure on how much investors…
Chewy (CHWY) is back in focus ahead of its fiscal second quarter earnings report on September 9, 2026, following a 2% daily gain and an increase of more than 15% over the past month. Chewy’s recent momentum, including an 18.36% 30-day share price return and a 16.52% 90-day share price return, comes against a weaker backdrop, with the year-to-date share price return down 26.28% and the 1-year total shareholder return down 39.41%. Seize this earnings momentum moment around Chewy to review a…
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
StockJumpers analysis and trade plans are finalized and uploaded generally one house before market cloase (3PM EST) for most events unless noticed.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
Members who are too busy to manual trade can use Trade Assist. For more information visit here
Avg Daily Volume: 4,074,368 Market Cap: 22.97B
Sector: None Short Interest: 28.21
Ticker delayed 20 minutes
NOTICE: All material on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.